Free Trial

Owens & Minor (OMI) Competitors

Owens & Minor logo
$7.83 -0.31 (-3.85%)
Closing price 06/11/2025 03:59 PM Eastern
Extended Trading
$7.84 +0.02 (+0.23%)
As of 06/11/2025 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OMI vs. MCK, COR, CAH, HSIC, PDCO, SEM, IMCR, GLPG, NVCR, and FOLD

Should you be buying Owens & Minor stock or one of its competitors? The main competitors of Owens & Minor include McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Select Medical (SEM), Immunocore (IMCR), Galapagos (GLPG), NovoCure (NVCR), and Amicus Therapeutics (FOLD). These companies are all part of the "medical" sector.

Owens & Minor vs. Its Competitors

Owens & Minor (NYSE:OMI) and McKesson (NYSE:MCK) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk.

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 3.7% of Owens & Minor shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

McKesson received 724 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 74.26% of users gave McKesson an outperform vote while only 47.95% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
257
47.95%
Underperform Votes
279
52.05%
McKessonOutperform Votes
981
74.26%
Underperform Votes
340
25.74%

McKesson has higher revenue and earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.72B0.06-$41.30M-$4.75-1.65
McKesson$359.05B0.25$3.00B$25.8327.75

Owens & Minor has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, McKesson has a beta of 0.49, meaning that its stock price is 51% less volatile than the S&P 500.

McKesson has a net margin of 0.82% compared to Owens & Minor's net margin of -0.46%. Owens & Minor's return on equity of 14.60% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.46% 14.60% 2.51%
McKesson 0.82%-181.26%5.34%

In the previous week, McKesson had 17 more articles in the media than Owens & Minor. MarketBeat recorded 39 mentions for McKesson and 22 mentions for Owens & Minor. McKesson's average media sentiment score of 1.17 beat Owens & Minor's score of 0.29 indicating that McKesson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
6 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
1 Very Negative mention(s)
Neutral
McKesson
27 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Owens & Minor currently has a consensus price target of $12.33, indicating a potential upside of 57.57%. McKesson has a consensus price target of $694.38, indicating a potential downside of 3.12%. Given Owens & Minor's higher probable upside, equities analysts clearly believe Owens & Minor is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
2 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
McKesson
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87

Summary

McKesson beats Owens & Minor on 14 of the 19 factors compared between the two stocks.

Get Owens & Minor News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMI vs. The Competition

MetricOwens & MinorMedical & hospital equipment IndustryMedical SectorNYSE Exchange
Market Cap$604.68M$7.80B$5.57B$19.81B
Dividend YieldN/A1.84%5.28%3.84%
P/E Ratio-12.0420.6527.1735.67
Price / Sales0.061.14409.7246.74
Price / Cash1.2510.7638.2517.52
Price / Book0.652.147.064.84
Net Income-$41.30M$259.21M$3.23B$1.02B
7 Day Performance2.92%1.32%2.89%1.94%
1 Month Performance9.39%1.57%9.06%3.03%
1 Year Performance-53.74%-1.00%31.40%9.73%

Owens & Minor Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMI
Owens & Minor
4.6246 of 5 stars
$7.83
-3.8%
$12.33
+57.6%
-53.6%$604.68M$10.72B-12.0422,500Analyst Revision
MCK
McKesson
4.3914 of 5 stars
$721.27
+0.2%
$686.69
-4.8%
+21.2%$90.24B$359.05B33.0375,000Positive News
Analyst Forecast
Insider Trade
COR
Cencora
4.4991 of 5 stars
$292.11
+0.3%
$301.18
+3.1%
+23.1%$56.62B$638.56M41.5542,000Positive News
CAH
Cardinal Health
4.5023 of 5 stars
$155.19
+0.5%
$146.43
-5.6%
+54.9%$37.04B$222.29B28.9546,500Positive News
Analyst Forecast
HSIC
Henry Schein
3.2154 of 5 stars
$69.56
-0.6%
$79.30
+14.0%
+7.0%$8.47B$12.67B28.6322,000Positive News
PDCO
Patterson Companies
1.4867 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700News Coverage
Upcoming Earnings
SEM
Select Medical
4.9949 of 5 stars
$15.11
-1.2%
$26.00
+72.1%
-54.4%$1.94B$5.22B9.1653,800Positive News
IMCR
Immunocore
2.9124 of 5 stars
$38.65
+5.6%
$58.89
+52.4%
-13.5%$1.94B$333.58M-40.68320Positive News
Analyst Revision
High Trading Volume
GLPG
Galapagos
0.3646 of 5 stars
$29.20
+1.5%
$25.33
-13.2%
+8.2%$1.92B$288.19M0.001,310Positive News
NVCR
NovoCure
4.0599 of 5 stars
$17.04
-10.8%
$32.83
+92.7%
-18.9%$1.90B$621.71M-12.171,320High Trading Volume
FOLD
Amicus Therapeutics
3.9526 of 5 stars
$6.16
+1.5%
$16.22
+163.3%
-41.0%$1.90B$543.14M-34.22480

Related Companies and Tools


This page (NYSE:OMI) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners